The Danish government has initiated a trial that allows doctors to prescribe medical cannabis to patients with chronic pain and severe nausea from chemotherapy. The trial will continue for the next four years and has received a grant worth €29 million ($34 million). In addition, research studies and gathering of knowledge in connection with the trial will receive funds worth €6.6 million ($7.7 million).
The Danish Medicines Agency has recommended four patient groups that can benefit from medical cannabis: multiple sclerosis, spinal cord injuries, chronic pain, and chemotherapy-induced nausea. However, a doctor is allowed to prescribe medical cannabis to patients with other conditions if it can be professionally justified.
From January 1, 2018, the medical cannabis will be handed out from pharmacies and hospitals.